All > Pain Management > Gabapentin

Gabapentin 300mg for Pain

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Pain+5 MoreGabapentin 300mg - Drug
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This study is evaluating whether a combination of gabapentin and pregabalin can reduce the amount of opioid pain medication used in orthopedic trauma patients.

Eligible Conditions
  • Pain
  • Trauma
  • Narcotics
  • Injury
  • Painkillers
  • Gabapentin

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Similar Trials

1
Gabapentin Arm
1
Gabapentin
1
Pregabalin 300mg

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: First 7 days post-enrolment or until discharge, if discharge < 7 days post-enrollment

Day 7
Hospital length of stay
Incentive spirometry values
Rate of intubation
Rate of unplanned ICU admission
Reduction in opioid usage
Day 7
Pain control

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
Gabapentin Arm
1
Gabapentin
2
Pregabalin 300mg

Trial Design

3 Treatment Groups

Neither Pregabalin nor Gabapentin
1 of 3
Gabapentin
1 of 3
Pregabalin
1 of 3

Active Control

Experimental Treatment

210 Total Participants · 3 Treatment Groups

Primary Treatment: Gabapentin 300mg · No Placebo Group · Phase 4

Gabapentin
Drug
Experimental Group · 1 Intervention: Gabapentin 300mg · Intervention Types: Drug
Pregabalin
Drug
Experimental Group · 1 Intervention: Pregabalin 50mg · Intervention Types: Drug
Neither Pregabalin nor Gabapentin
Drug
ActiveComparator Group · 1 Intervention: Neither Pregabalin nor Gabapentin · Intervention Types: Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gabapentin
FDA approved
Pregabalin
FDA approved

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: first 7 days post-enrolment or until discharge, if discharge < 7 days post-enrollment

Who is running the clinical trial?

CAMC Health SystemLead Sponsor
44 Previous Clinical Trials
7,466 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Hospitalization is projected to exceed 24 hours from the time of consent.
You are eligible for Nurse Practitioner service admittance.
You must be a minimum of 18 years old to participate.
Patients are enrolled within three-sixths of a day after admission.
You possess an active opioid prescription at the time of enrollment.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top